Read + Share
Amedeo Smart
Independent Medical Education
Zhang H, Yang Y, Li J, Wang M, et al. A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. PLoS Comput Biol 2020;16:e1008489.PMID: 33382685
Email
LinkedIn
Facebook
Twitter
Privacy Policy